Barely Significant
← all excerpts

RAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancer.

Nat Commun · 2021 · PMC8571323 · PMID 34741021

Europe PMCDOI
1
hedged sentence
0.0300
closest p · 0.6× alpha
0.0300
boldest claim

The sentences

highly significantp < 0.03actually significant
A highly significant ( p < 0.03) difference in PFS was found between patients with RAB5A Allred scores 7 and 8, where 7/8 patients had a PFS of 50 weeks or more, and Allred scores 0-6, where all patients had PFS less than 50 weeks (Fig. 6A ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.